The Recall Desk
HighFDA (Devices)·Z-1657-2026·Announced 2026-04-08

[pending] Atellica CH Enzymatic Hemoglobin A1c (A1c_E); Siemens Material Number (SMN): 11097536;

Pending LLM rewrite. Source: FDA_DEVICE Z-1657-2026.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Pending LLM scoring against the rubric.

Plain-English summary

A potential for depressed results for Atellica CH A1c_E when processing Atellica CH RCRP on the same analyzer. Customers processing A1c_E and RCRP on separate analyzers are not impacted by the recall. The frequency and magnitude of the negative bias and imprecision increase over time and are not consistent with the assay Instructions For Use (IFU). When this issue is present, Quality Control (QC) results demonstrate a negative trend and increased imprecision. The clinical impact of a negative (A1c_E) bias may lead to a delay in diagnosis for diabetes or lead to less-than-optimal treatment for existing diabetes.

The recalled product

Product
Atellica CH Enzymatic Hemoglobin A1c (A1c_E); Siemens Material Number (SMN): 11097536;
Manufacturer
Siemens Healthcare Diagnostics, Inc.

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • Siemens Material Number (SMN): 11097536
  • UDI-DI: 00630414220505
  • Lot numbers: 150131
  • 150132
  • 150232
  • 150260
  • 150283
  • 150344
  • 150361
  • 150365
  • 150366
  • 150445
  • 150453
  • 150460
  • 150498
  • 150505
  • 150562
  • 150600
  • 150618
  • 150621

Distribution

Distributed nationwide across the United States.